Biomed Data J.2015;1(1) Open Access to Experimental and Clinical Data
Editor: Prof. Constantinos Pantos, NKUA
This pilot issue presents the rationale for launching a data journal in the biomedical field and the foundations of our editorial policy, the policy of the European Commission on open-access to scientific publications and research data in Horizon 2020, and the use of datasets as a basis for computational modelling of diseases, with focus on cancer. The second group of papers analyse the need for open access, structured data of assured quality in the fields of clinical brain research, endocrine research, cardiology research, and drug discovery. The final section looks at two specific aspects: the legal challenges of publishing open-access biomedical data and the information infrastructure, supporting the formulation of the journal policy, the publication process, and impact assessment.
Editorial
Open Data Access Policy
. The Biomedical Data Journal in the New Era of Open Access to Scientific Information. Biomed Data J. 2015;1(1):05-10.
. Computational Modelling in Cancer: Methods and Applications. Biomed Data J. 2015;1(1):15-25.
. The Need for Open-access, Structured Data in Clinical Brain Research. Biomedical Data Journal. 2015;1(1):27-32.
. The Need for Open-access, Structured Data in Endocrine Research. Biomed Data J. 2015;1(1):33-35.
. The Need for Open-access Structured Data in Cardiology Research. Biomed Data J. 2015;1(1):36-38.
. Open-access and Structured Data in Drug Discovery. Biomed Data J. 2015;1(1):39-41.
. Publishing Open-Access Biomedical Data: Legal Challenges. Biomed Data J. 2015;1(1):43-51.
. OSL Platform: A Link to Open-access Scientific Information and Structured Data. Biomed Data J. 2015;1(1):52-54.
